Bevenopran is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.

Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively[1].

676500-67-7

C20H26N4O4

386.44

CB-5945;ADL-5945

DMSO:120 mg/mL (310.53 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years